JERUSALEM--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd (NYSE:TEVA) announced today that it had launched a generic version of Viagra® (sildenafil) immediately on patent expiry in Germany, the United Kingdom, Italy, the Netherlands, Switzerland, Ireland, Austria, Belgium and Denmark. The company had already launched the product in Spain, Canada and certain other countries. Dipankar Bhattacharjee, President and CEO Europe Generics, welcomed the launch: “Teva has a proud track record of brin
Reported by Business Wire 18 hours ago.
↧